Delivery Order SPE2DB22D2211-SPE2DB23FPEH8

Award Date 9/14/23
Potential Completion Date 9/15/23
Potential Value $29
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $86,400 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 18,000 boxes of Chloraseptic sore throat lozenges. The single award delivery order was issued against an unidentified indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen. Performance will occur at the prime contractor's facility in Conshohocken, Pennsylvania with delivery required by August 28, 2023 to support the DLA's medical supply needs. No...
The Defense Logistics Agency awarded a $436 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 18 count bottles of Chloraseptic sore throat lozenges. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania distribution facility. The single day order runs from September 7th through the 8th of 2023 under the parent company Amerisourcebergen Corporation's indefinite delivery vehicle with DLA. No set aside designation or subcontractors are indicated. This...
The Defense Logistics Agency awarded a $145 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 18 count packages of Chloraseptic sore throat lozenges. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order runs from July 10th through July 11th, 2023 under the parent company Amerisourcebergen Corporation's indefinite delivery vehicle with DLA. As a leading provider of pharmaceuticals and medical supplies,...
The Defense Logistics Agency awarded a $28,800 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562216682 Chloraseptic sore throat lozenges. The single day contract has a period of performance from September 18-19, 2023, with all work to be conducted by Amerisourcebergen at its facility located in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing DLA-wide...
The Defense Logistics Agency awarded a $368 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 18 count packages of Chloraseptic sore throat lozenges. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 7-8, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen will fulfill this order to support the DLA's stocking of common over-the-counter medications for military treatment facilities and...
The Defense Logistics Agency awarded a $299.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 18 boxes of Chloraseptic sore throat lozenges. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for one day's supply to support DLA requirements. As a top pharmaceutical distributor, Amerisourcebergen will deliver the requested over-the-counter medication from its existing inventory and distribution infrastructure under the...
The Defense Logistics Agency awarded a $12,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561375663 Chloraseptic sore throat lozenges. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from June 29, 2023 to June 30, 2023. No...
The Defense Logistics Agency awarded a $28,800 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 18 boxes of Chloraseptic sore throat lozenges. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is September 6-7, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill this order to supply sore throat medication to the DLA. No major subcontractors or...
The Defense Logistics Agency awarded a $303,840 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 18,000 packages of Chloraseptic sore throat lozenges. The single day contract has a period of performance from July 11, 2023 through July 12, 2023, with all work to be conducted by the prime contractor in Conshohocken, Pennsylvania. No additional details were provided regarding the underlying requirements or vehicle against which this order was placed. The award utilizes...
The Defense Logistics Agency awarded a $122,300 firm fixed price delivery order to Amerisourcebergen Drug Corporation for chloraseptic sore throat lozenges. Under this contract, Amerisourcebergen will provide 18,000 boxes of Chloraseptic sore throat lozenges to the Defense Logistics Agency. The place of performance is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. The period of performance is July 17-18, 2023. No major subcontractors or set aside designations were...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB23FPEH8
    Delivery Order

The Defense Logistics Agency awarded a $28,800 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562180629 Chloraseptic sore throat lozenges. The order is for 18 count packages of the over-the-counter medication to support DLA programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from September 14 to 15, 2023. No subcontractors or set aside designations were identified. This order was issued under an existing DLA pharmaceutical supply vehicle to fulfill internal health and medical needs.

Generated 12/24/23, 2:04 PM